Stock-based Compensation (Details) - USD ($) $ in Millions |
1 Months Ended | 3 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Apr. 06, 2020 |
Feb. 17, 2021 |
Mar. 31, 2022 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Jul. 15, 2021 |
|
| Stock-based Compensation (Details) [Line Items] | ||||||
| Common stock, shares reserved for issuance | 1,302,326 | |||||
| Increase in issuance of authorized shares | 348,837 | 1,767,442 | ||||
| authorized for issuance | 465,116 | |||||
| Shares available for future grant | 17,442 | |||||
| Unrecognized compensation cost (in Dollars) | $ 1.8 | |||||
| Weighted average period | 2 years 3 months 18 days | |||||
| Expected dividend | 0.00% | |||||
| Two Thousand Nineteen [Member] | ||||||
| Stock-based Compensation (Details) [Line Items] | ||||||
| Authorized for issuance of shares | 232,558 | |||||
| Shares issued for future grants | 75,581 | |||||
| X | ||||||||||
- Definition ExpectedDividend No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Aggregate number of common shares reserved for future issuance. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The maximum number of shares (or other type of equity) that have been approved for issuance in the equity-based payment transaction. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of cost expensed and capitalized for award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of stock issued attributable to transactions classified as other. No definition available.
|
| X | ||||||||||
- Details
|